ProPhase Labs to Present at the NobleCon17 Annual Small & Microcap Investor Conference on Tuesday, January 19, 2021 at 12:45 p.m. Eastern Time
January 11, 2021 08:30 ET
|
ProPhase Labs, Inc.
Company Exceeding Near Term Goals & Expands 2021 Testing Capacity Surpasses Targeted $30 Net Profit Margin Per COVID-19 Test GARDEN CITY, NY, Jan. 11, 2021 (GLOBE NEWSWIRE) -- ProPhase...
ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants
January 05, 2021 12:10 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced that it has entered into a definitive...
ProPhase Labs Expands COVID-19 Testing Capacity with New 25,000 Square Feet Testing Facility in Garden City, New York
December 08, 2020 16:15 ET
|
ProPhase Labs, Inc.
Company Expands to Meet Anticipated Demand for Increased Molecular Testing From New Business Opportunities – Aiming For Capacity to Process 50,000 Tests per Day Doylestown, PA, Dec. 08, 2020 (GLOBE...
ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2020
November 16, 2020 08:30 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 16, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced net sales of $3.8 million for...
ProPhase Labs to Present at the Virtual Fall Investor Summit on Monday, November 16, 2020 at 2:30 p.m. Eastern Time
November 10, 2020 08:30 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, PA , Nov. 10, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase Labs”), a diversified medical science and technology company, today announced that management will...
ProPhase Labs Completes Acquisition of CLIA Accredited Lab and Provides Corporate Update
November 02, 2020 08:30 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 02, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has completed the...
ProPhase Labs Announces Definitive Agreement to Acquire CLIA Accredited Lab Certified for COVID-19 and Upper Respiratory Testing
October 23, 2020 08:30 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Oct. 23, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today a definitive agreement to...
ProPhase Labs Engages Industry Expert to Advise on Possible Acquisition of CLIA Accredited Labs Certified for COVID-19 and Other Testing
September 30, 2020 17:04 ET
|
ProPhase Labs, Inc.
Company Enters into Consulting Agreement and Amended and Restated Promissory Note and Security Agreement with Predictive Laboratories, Inc. to Further These Plans DOYLESTOWN, Pennsylvania, Sept. 30,...
ProPhase Labs Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program
September 30, 2020 08:30 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Sept. 30, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, has engaged international investor relations...
ProPhase Labs Announces At-The-Market Equity Facility
September 23, 2020 16:10 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Sept. 23, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today announced that it has entered into an at-the-market (“ATM”) equity...